• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Idiopathic Pulmonary Fibrosis (IPF) 
Trial Solutions

Enhancing study success with advanced clinical IPF trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing IPF research

Among interstitial lung diseases, Idiopathic Pulmonary Fibrosis remains an area with high mortality and extremely limited treatment options. Your IPF research program represents hope to millions of patients. That's why we tailored our Signant SmartSignals solutions to address research challenges so you can deliver new and better treatment options.

IPF-1

Why Signant Health

  • Conduct 6MWT Consistently
  • Reduce Participant Burdens
  • Collect Accurate COA Data
  • Gain Expert Guidance
  • Improve Operational Efficiency
  • Digitalize the Process
  • Conduct 6MWT Consistently

    Conduct 6MWT Consistently

    Variability and inconsistency in the administration of the six-minute walk test results in unreliable assessment and endpoint data. Signant's Rater Training solution and video production services ensure raters conduct the 6MWT correctly and consistently across sites and studies.
     

  • Reduce Participant Burdens

    Reduce Participant Burdens

    IPF makes everyday tasks difficult for patients. Simplify the clinical trial participation experience by providing tools like eConsent and Telemedicine that reduce the need for complicated form completions or site visits. As an added bonus, sites benefit by maintaining up-to-date ICFs and consulting with patients remotely.
     

  • Collect Accurate COA Data

    Collect Accurate COA Data

    If your protocol requires L-IPF, Cough VAS, PGI-C/S, or other site-based questionnaires, leverage our eCOA platform to  collect more complete and accurate data. In addition, this method reduces burden of use for both patients and sites.
     

  • Gain Expert Guidance

    Gain Expert Guidance

    From consulting on outcome measure selection to scale management and rater training services, Signant’s in-house experts will help you navigate common IPF challenges from study launch to closeout. Talk through your protocol with experienced clinical science and medicine experts.
     

  • Improve Operational Efficiency

    Improve Operational Efficiency

    Conducting studies in many countries and across many sites introduces logistical challenges that can be the source of errors or delays. Study teams trust our RTSM system to not only launch studies faster but to handle complex cohorting, study supply forecasting, and data transfers with efficiency and accuracy.
     

  • Digitalize the Process

    Digitalize the Process

    Any of our clinical research technology solutions and services can be used individually, but when you combine them, your study will be optimized from end-to-end to deliver accurate endpoint data.
     

Comprehensive IPF experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our IPF trial resources
SOLUTION BROCHURE

IPF Trial Solutions Overview


GET INSIGHTS
VIDEO

IPF Trial Solutions


WATCH [2 MIN]
SOLUTION

Rater Training & Qualification

 
LEARN MORE

eClinical solutions for IPF trials

Ready to learn more?

Discover how Signant can support your current or upcoming IPF trials. 

DOWNLOAD BROCHURE GET STARTED